Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
30.48
+0.13 (0.43%)
At close: Aug 13, 2025, 4:00 PM
29.97
-0.51 (-1.67%)
Pre-market: Aug 14, 2025, 8:11 AM EDT
Amphastar Pharmaceuticals Employees
Amphastar Pharmaceuticals had 2,028 employees as of December 31, 2024. The number of employees increased by 267 or 15.16% compared to the previous year.
Employees
2,028
Change (1Y)
267
Growth (1Y)
15.16%
Revenue / Employee
$356,351
Profits / Employee
$66,424
Market Cap
1.42B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AMPH News
- 1 day ago - Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum - Benzinga
- 2 days ago - Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd. - Accesswire
- 3 days ago - Amphastar Announces FDA Approval for Iron Sucrose Injection, USP - Accesswire
- 6 days ago - Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025 - Accesswire
- 16 days ago - Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More - Seeking Alpha
- 16 days ago - Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025 - Accesswire
- 4 weeks ago - Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters - Accesswire